SPOP and prostate cancer: However, SPOP has a high mutation frequency in human tumor samples, with mutations occurring mainly in the MATH structural domain; these mutations cause inactivation of SPOP function, which leads to tumor progression, and SPOP mutations are more prevalent in prostate cancer and endometrial cancer [16].